Advertisement

Rheumatology International

, Volume 38, Issue 8, pp 1399–1411 | Cite as

Mesenchymal stem cells injections for knee osteoarthritis: a systematic overview

  • Dan Xing
  • Qi Wang
  • Ziyi Yang
  • Yunfei Hou
  • Wei Zhang
  • Yaolong Chen
  • Jianhao Lin
Systematic Review

Abstract

Numerous systematic reviews investigating the effects of mesenchymal stem cells (MSCs) in treating knee osteoarthritis (OA) have been published with controversial conclusion. The purpose of the overview was (1) to perform an overview of systematic reviews investigating MSCs for knee OA and (2) to synthesize evidence qualitatively to assess confidence in the review findings. A systematic search of systematic reviews published through Aug 2017 was conducted using the MEDLINE, EMBASE and Cochrane Library. The methodological quality and risk of bias of included systematic reviews was assessed by AMSTAR instrument and ROBIS tool, respectively. Best evidence choice procedure was conducted according to the Jadad decision algorithm. The systematic reviews with high methodological quality and low risk of bias were selected ultimately for further evidence synthesis based on the CERQual tool. Four systematic reviews were eligible for inclusion. According to the ROBIS tool, there was one systematic review with low risk of bias and three with high risk of bias. Thus, only one systematic review conducted by Pas et al. with highest AMSTAR score and low risk of bias was selected. For all outcomes after evidence synthesis via the CERQual tool, confidence for decision making was either low (self-reported measurement and MRI/histological outcome) or moderate (adverse events). The present study demonstrates that moderate confidence could be placed in safety of MSCs therapy for knee OA, but with low confidence in efficacy outcomes due to limitations of the current evidence. Further high-quality studies with high internal and external validity are still required.

Keywords

Mesenchymal stem cell Knee osteoarthritis CERQual Overview ROBIS 

Notes

Acknowledgements

The authors thank Professor Joey Kwong from Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan for her great advice on methodology in interpreting the evidence. We also thank Professor Wei Liu from Department of Biomedical Engineering, School of Medicine, Tsinghua University for his sharing knowledge about basic research in mesenchymal stem cells.

Author contributions

Project conceptualization: D Xing and JH Lin. Study design: D Xing, Q Wang and JH Lin. Data collection/validation: D Xing, Q Wang, ZY Yang and JH Lin. Data analysis: D Xing, Q Wang and YF Hou. Result interpretation: D Xing, Q Wang, Q Liu and YF Hou. Reporting & editing: D Xing, YF Hou and W Zhang. Final approval of the version to be submitted: D Xing, Q Wang and JH Lin. Project guarantor: YL Chen and JH Lin.

Compliance with ethical standards

Funding

This study was supported by grants from the National Natural Science Foundation of China (No. 81501919) and Peking University People's Hospital Scientific Research Development Funds (No. RDH2017-05).

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

This article does not contain any studies with human participants performed by any of the authors.

Supplementary material

296_2017_3906_MOESM1_ESM.doc (64 kb)
Supplementary material 1 (DOC 64 KB)
296_2017_3906_MOESM2_ESM.docx (14 kb)
Supplementary material 2 (DOCX 13 KB)

References

  1. 1.
    Sacks JJ, Luo YH, Helmick CG (2010) Prevalence of specific types of arthritis and other rheumatic conditions in the ambulatory health care system in the United States, 2001–2005. Arthritis Care Res (Hoboken) 62(4):460–464CrossRefGoogle Scholar
  2. 2.
    Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58(1):26–35CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Helmick CG, Felson DT, Lawrence RC et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58(1):15–25CrossRefPubMedGoogle Scholar
  4. 4.
    Kane P, Frederick R, Tucker B et al (2013) Surgical restoration/repair of articular cartilage injuries in athletes. Phys Sportsmed 41:75–86CrossRefPubMedGoogle Scholar
  5. 5.
    Nyvang J, Hedström M, Gleissman SA (2016) It’s not just a knee, but a whole life: a qualitative descriptive study on patients’ experiences of living with knee osteoarthritis and their expectations for knee arthroplasty. Int J Qual Stud Health Well-being 11:30193CrossRefPubMedGoogle Scholar
  6. 6.
    Crawford DC, Miller LE, Block JE (2013) Conservative management of symptomatic knee osteoarthritis: a flawed strategy. Orthop Rev (Pavia) 5(1):e2CrossRefGoogle Scholar
  7. 7.
    de Girolamo L, Kon E, Filardo G et al (2016) Regenerative approaches for the treatment of early OA. Knee Surg Sports Traumatol Arthrosc 24:1826–1835CrossRefPubMedGoogle Scholar
  8. 8.
    Carstairs A, Genever P (2014) Stem cell treatment for musculoskeletal disease. Curr Opin Pharmacol 16:1–6CrossRefPubMedGoogle Scholar
  9. 9.
    Freitag J, Bates D, Boyd R et al (2016) Mesenchymal stem cell therapy in the treatment of osteoarthritis: reparative pathways, safety and efficacy—a review. BMC Musculoskelet Disord 17:230CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Peeters CM, Leijs MJ, Reijman M et al (2013) Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage 21:1465–1473CrossRefPubMedGoogle Scholar
  11. 11.
    Wei CC, Lin AB, Hung SC (2014) Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry. Cell Transplant 23:505–512CrossRefPubMedGoogle Scholar
  12. 12.
    Pers YM, Ruiz M, Noël D et al (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthritis Cartilage 23:2027–2035CrossRefPubMedGoogle Scholar
  13. 13.
    Castro-Manrreza ME, Montesinos JJ (2015) Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications. J Immunol Res 2015:394917Google Scholar
  14. 14.
    Turner L, Knoepfler P (2016) Selling Stem Cells in the USA: assessing the Direct-to-Consumer Industry. Cell Stem Cell 19:154–157CrossRefPubMedGoogle Scholar
  15. 15.
    Koh YG, Choi YJ (2012) Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 19:902–907CrossRefPubMedGoogle Scholar
  16. 16.
    Koh YG, Kwon OR, Kim YS et al (2014) Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30:1453–1460CrossRefPubMedGoogle Scholar
  17. 17.
    Saw KY, Anz A, Siew-Yoke JC et al (2013) Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy 29:684–694CrossRefPubMedGoogle Scholar
  18. 18.
    Vega A, Martín-Ferrero MA, Del CF et al (2015) Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation 99:1681–1690CrossRefPubMedGoogle Scholar
  19. 19.
    Wong KL, Lee KB, Tai BC et al (2013) Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy 29:2020–2028CrossRefPubMedGoogle Scholar
  20. 20.
    Osborne H, Castricum A (2016) Change to Australasian College of Sport and Exercise Physicians-position statement: the place of mesenchymal stem/stromal cell therapies in sport and exercise medicine. Br J Sports Med 50:1229CrossRefPubMedGoogle Scholar
  21. 21.
    Yubo M, Yanyan L, Li L et al (2017) Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: a meta-analysis. PLoS One 12:e0175449CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Cui GH, Wang YY, Li CJ et al (2016) Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: a meta-analysis. Exp Ther Med 12:3390–3400CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Xia P, Wang X, Lin Q et al (2015) Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop 39:2363–2372CrossRefPubMedGoogle Scholar
  24. 24.
    Pas HI, Winters M, Haisma HJ et al (2017) Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br J Sports Med 51:1125–1133CrossRefPubMedGoogle Scholar
  25. 25.
    Filardo G, Perdisa F, Roffi A, Marcacci M, Kon E (2016) Stem cells in articular cartilage regeneration. J Orthop Surg Res 11:42CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Robinson KA, Chou R, Berkman ND et al (2016) Twelve recommendations for integrating existing systematic reviews into new reviews: EPC guidance. J Clin Epidemiol 70:38–44CrossRefPubMedGoogle Scholar
  28. 28.
    Shea BJ, Grimshaw JM, Wells GA et al (2007) Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Shea BJ, Bouter LM, Peterson J et al (2007) External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One 2(12):e1350CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Jadad AR, Cook DJ, Browman GP (1997) A guide to interpreting discordant systematic reviews. CMAJ 156(10):1411–1416PubMedPubMedCentralGoogle Scholar
  31. 31.
    Whiting P, Savović J, Higgins JP et al (2016) ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol 69:225–234CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lewin S, Glenton C, Munthe-Kaas H et al (2015) Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med 12:e1001895CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Guyatt G, Oxman AD, Akl EA et al (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394CrossRefPubMedGoogle Scholar
  34. 34.
    Carstensen K, Lou S, Groth JL et al (2017) Psychiatric service users’ experiences of emergency departments: a CERQual review of qualitative studies. Nord J Psychiatry 71:315–323CrossRefPubMedGoogle Scholar
  35. 35.
    Young D (2005) Policymakers, experts review evidence-based medicine. Am J Health Syst Pharm 62(4):342–343PubMedGoogle Scholar
  36. 36.
    Kristjánsson B, Honsawek S (2014) Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells Int 2014:194318Google Scholar
  37. 37.
    Bekkers JE, Bartels LW, Benink RJ, Tsuchida AI, Vincken KL, Dhert WJ et al (2013) Delayed gadolinium enhanced MRI of cartilage (dGEMRIC) can be effectively applied for longitudinal cohort evaluation of articular cartilage regeneration. Osteoarthritis Cartil 21:943–949CrossRefGoogle Scholar
  38. 38.
    Tan YH, Jiang MM, Yu HY et al (2013) Therapeutic effect of arthroscopy combined with autologous bone marrow stem cell grafting on knee osteoarthritis. J Trad 25(10):35–38Google Scholar
  39. 39.
    Nejadnik H, Hui JH, Feng CEP et al (2010) Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med 38(6):1110–1116CrossRefPubMedGoogle Scholar
  40. 40.
    Vangsness CT, Farr J, Boyd J et al (2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am 96(2):90–98CrossRefPubMedGoogle Scholar
  41. 41.
    Akgun I, Unlu MC, Erdal OA et al (2015) Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Arch Orthop Trauma Surg 135(2):251–263CrossRefPubMedGoogle Scholar
  42. 42.
    Liang HS, Huang K, Lin L et al (2015) Arthroscopic microfracture surgery combined with autologous bone marrow mesenchymal stem cells transplant in the treatment of knee cartilage defect. Chin J Mod Drug App 9(9):1–3Google Scholar
  43. 43.
    Lv XX, Huang C, Yin Z et al (2015) Effectiveness of autologous bone marrow mesenchymal stem cell transplant for knee osteoarthritis. Chin J Cell Stem Cell 5(2):28–32Google Scholar
  44. 44.
    Varma HS, Dadarya B, Vidyarthi A (2010) The new avenues in the management of osteo-arthritis of knee--stem cells. J Indian Med Assoc 108(9):583–585PubMedGoogle Scholar
  45. 45.
    Orozco L, Munar A, Soler R et al (2014) Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-year follow-up results. Transplantation 97(11):e66–e68CrossRefPubMedGoogle Scholar
  46. 46.
    Gan FY, Tang C, Guo DB et al (2014) The treatment of mesenchymal stem cell transplantation for knee osteoarthritis: a clinical observation study. Modern Diagn Treat 1(15):3512–3513Google Scholar
  47. 47.
    Davatchi F, Sadeghi AB, Mohyeddin M et al (2016) Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three patients. Int J Rheum Dis 19:219–225CrossRefPubMedGoogle Scholar
  48. 48.
    Emadedin M, Aghdami N, Taghiyar L et al (2012) Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 15(7):422–428PubMedGoogle Scholar
  49. 49.
    Koh YG, Jo SB, Kwon OR et al (2013) Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 29(4):748–755CrossRefPubMedGoogle Scholar
  50. 50.
    Buda R, Vannini F, Cavallo M et al (2010) Osteochondral lesions of the knee: a new one-step repair technique with bone-marrow-derived cells. J Bone Joint Surg Am 92 Suppl 2:2–11CrossRefPubMedGoogle Scholar
  51. 51.
    Gobbi A, Karnatzikos G, Scotti C et al (2011) One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2-year follow-up. Cartilage 2(3):286–299CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Turajane T, Chaweewannakorn U, Larbpaiboonpong V et al (2013) Combination of intra-articular autologous activated peripheral blood stem cells with growth factor addition/ preservation and hyaluronic acid in conjunction with arthroscopic microdrilling mesenchymal cell stimulation Improves quality of life and regenerates articular cartilage in early osteoarthritic knee disease. J Med Assoc Thai 96(5):580–588PubMedGoogle Scholar
  53. 53.
    Orozco L, Munar A, Soler R et al (2013) Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 95(12):1535–1541CrossRefPubMedGoogle Scholar
  54. 54.
    Kim JD, Lee GW, Jung GH et al (2014) Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol 24(8):1505–1511CrossRefPubMedGoogle Scholar
  55. 55.
    Koh YG, Choi YJ, Kwon SK et al (2015) Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 23(5):1308–1316CrossRefPubMedGoogle Scholar
  56. 56.
    Gobbi A, Karnatzikos G, Sankineani SR (2014) One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee. Am J Sports Med 42(3):648–657CrossRefPubMedGoogle Scholar
  57. 57.
    Jo CH, Lee YG, Shin WH et al (2014) Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells 32(5):1254–1266CrossRefPubMedGoogle Scholar
  58. 58.
    Kim YS, Choi YJ, Suh DS et al (2015) Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effective as a scaffold. Am J Sports Med 43(1):176–185CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Arthritis Clinic & Research Center, Peking University People’s HospitalPeking UniversityBeijingChina
  2. 2.Arthritis InstitutePeking UniversityBeijingChina
  3. 3.Evidence-Based Medicine Center, School of Basic Medical SciencesLanzhou UniversityGansuChina
  4. 4.Chinese GRADE CenterGansuChina

Personalised recommendations